← Open Payments lookup

GRACE PFEIFER: Open Payments

NPI 1184297558 · AMSTERDAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,761 in 59 payments from 12 companies in 2025. Trend: 2023 $759 · 2024 $1,182 · 2025 $1,761

Food & beverage: $1,761
CompanyPaymentsAmount
ABBVIE INC.19$507
Teva Pharmaceuticals USA, Inc.10$278
E.R. Squibb & Sons, L.L.C.2$231
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$229
Axsome Therapeutics, Inc.3$168
Neurocrine BioSciences, Inc.4$89
Supernus Pharmaceuticals, Inc.3$66
Janssen Pharmaceuticals, Inc2$55
Takeda Pharmaceuticals U.S.A., Inc.2$46
Alkermes, Inc.2$41

Products named: VRAYLAR, COBENFY, CAPLYTA, UZEDY, Auvelity, INGREZZA, AUSTEDO XR, Qelbree.

Industry payments across NY — which companies pay providers there.